In some diseases, such as AD, the reduced GLUT-1 and GLUT-3 levels may weaken the glucose-transporting capability, leading to reduced glucose uptake, and this impairment appears to be a cause of neurodegeneration [43]. This evidence concerns the gene SLC2A1 and Alzheimer disease.